Family Medicine in Longmont, CO
76 verified family medicine doctors in Longmont. Page 2 of 2.
Family medicine physicians provide comprehensive primary care for patients of all ages, from newborns to seniors — managing everyday illness, chronic conditions, and preventive care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Tobey Schultz, DO
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. James Keeling, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Joshua Bailey, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sarah Jones Ketter, DO
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Danielle Trujillo, DO
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kate Weniger, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. James Mccarrey, DO
Family Medicine
CMS Open Payments· $31.19 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$31.19
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 72th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to James Mccarrey do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Laura Mischell, DO
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Matthew Gleaton, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Rhea Teasley-Bennett, MD
Family Medicine
CMS Open Payments· $46.23 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$46.23
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 75th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Rhea Teasley-Bennett do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ryan Kula, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Shahbaz Afzal, DO
Family Medicine
CMS Open Payments· $2,500 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,500
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Shahbaz Afzal do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Maura Doran-Snyder, MD
Family Medicine
CMS Open Payments· $159.30 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$159.30
Total received
6
Transactions
6
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Maura Doran-Snyder do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Matthew Velarde, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Paul Bridges, DO
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Egor Pakhomov, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.